Issue of US patent for S-PURE pressure-sensitive adhesive

Medherant is pleased to announce that the US Patent and Trademark Office has issued patent US12,774,407B2 which covers Medherant’s S-PURE pressure-sensitive adhesive.

“Issue of this patent adds to Medherant’s IP portfolio covering our S-PURE adhesive which we have developed for use in creating transdermal drug delivery patches and other applications where the excellent wearability for patients can be especially beneficial,” commented Professor David Haddleton, Medherant founder, Chief Scientific Officer and co-inventor of this patent.

Medherant is utilising the S-PURE adhesive for the development of the testosterone TEPI Patch that is in clinical development for the treatment of hypoactive sexual desire disorder in post-menopausal women.